相似文献
1
Dispelling the myths of providing dialysis in low- and middle-income countries.
Nat Rev Nephrol. 2021 Jan;17(1):11-12. doi: 10.1038/s41581-020-00346-7.
2
A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies.
Nephrol Dial Transplant. 2020 Jun 1;35(6):979-986. doi: 10.1093/ndt/gfaa035.
3
Increasing access to integrated ESKD care as part of universal health coverage.
Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005.
4
How can we achieve global equity in provision of renal replacement therapy?
Bull World Health Organ. 2008 Mar;86(3):229-37. doi: 10.2471/blt.07.041715.
5
Dialysis Care and Dialysis Funding in Asia.
Am J Kidney Dis. 2020 May;75(5):772-781. doi: 10.1053/j.ajkd.2019.08.005. Epub 2019 Nov 5.
6
Is renal replacement therapy for all possible in developing countries?
Ethn Dis. 2006 Spring;16(2 Suppl 2):S2-70-2.
7
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.
Am J Kidney Dis. 2021 Mar;77(3):315-325. doi: 10.1053/j.ajkd.2020.05.032. Epub 2020 Aug 12.
8
End-stage renal care in developing countries: the India experience.
Ren Fail. 2004 May;26(3):201-8. doi: 10.1081/jdi-120039516.
9
Public-private partnership in Hungarian dialysis care.
Nephrol Dial Transplant. 2006 Jul;21(7):2024-5; author reply 2025. doi: 10.1093/ndt/gfl156. Epub 2006 Apr 27.
10
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines.
Nephrology (Carlton). 2021 Feb;26(2):170-177. doi: 10.1111/nep.13830. Epub 2021 Jan 13.
引用本文的文献
1
Quality of Life in Patients with CKD With Catastrophic Health Care Expenditures: A National Study From Thailand.
Kidney Med. 2025 Feb 27;7(5):100987. doi: 10.1016/j.xkme.2025.100987. eCollection 2025 May.
2
The International Society of Nephrology Collaborative Quality Framework to Support Safe and Effective Dialysis Provision in Resource-Challenged Settings.
Kidney Int Rep. 2024 Dec 4;10(3):663-672. doi: 10.1016/j.ekir.2024.11.1366. eCollection 2025 Mar.
3
Global Policy and Advocacy Initiatives for Improving Kidney Care: Report from the 2023 International Society of Nephrology Global Kidney Health Atlas.
Kidney360. 2025 Mar 1;6(3):369-378. doi: 10.34067/KID.0000000651. Epub 2024 Nov 19.
4
International equity in access to home dialysis.
Curr Opin Nephrol Hypertens. 2025 Jan 1;34(1):112-120. doi: 10.1097/MNH.0000000000001027. Epub 2024 Sep 19.
5
Cost-benefit analysis of haemodialysis in patients with end-stage kidney disease in Abuja, Nigeria.
Health Econ Rev. 2024 Jul 3;14(1):47. doi: 10.1186/s13561-024-00529-z.
6
Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda.
Cost Eff Resour Alloc. 2024 Apr 30;22(1):35. doi: 10.1186/s12962-024-00545-0.
7
Balancing the health benefits and climate mortality costs of haemodialysis.
Future Healthc J. 2023 Nov;10(3):308-312. doi: 10.7861/fhj.2022-0127.
8
Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19.
Kidney Dis (Basel). 2022 Jun 15;8(5):357-367. doi: 10.1159/000525046. eCollection 2022 Nov.
9
The hidden financial catastrophe of chronic kidney disease under universal coverage and Thai "Peritoneal Dialysis First Policy".
Front Public Health. 2022 Oct 13;10:965808. doi: 10.3389/fpubh.2022.965808. eCollection 2022.
10
The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
BMC Med. 2022 Aug 2;20(1):247. doi: 10.1186/s12916-022-02438-6.
本文引用的文献
1
Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.
Kidney Int Suppl (2011). 2020 Mar;10(1):e63-e71. doi: 10.1016/j.kisu.2019.11.004. Epub 2020 Feb 19.
2
To include or not include: renal dialysis policy in the era of universal health coverage.
BMJ. 2020 Jan 28;368:m82. doi: 10.1136/bmj.m82.
3
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.
BMJ. 2019 Oct 31;367:l5873. doi: 10.1136/bmj.l5873.
4
The Affordable Dialysis Prize steams ahead.
Lancet. 2016 Mar 12;387(10023):1040. doi: 10.1016/S0140-6736(16)00657-7.
5
Worldwide access to treatment for end-stage kidney disease: a systematic review.
Lancet. 2015 May 16;385(9981):1975-82. doi: 10.1016/S0140-6736(14)61601-9. Epub 2015 Mar 13.
6
A literature review of the disruptive effects of user fee exemption policies on health systems.
BMC Public Health. 2012 Jun 8;12:289. doi: 10.1186/1471-2458-12-289.
7
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease.
CMAJ. 2012 Mar 20;184(5):E277-83. doi: 10.1503/cmaj.111355. Epub 2012 Feb 6.
8
Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes?
Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S30-40. doi: 10.2215/CJN.04000609.
9
End-stage renal disease in Indonesia: treatment development.
Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-33-6.
Zotero 插件